Activity in Biological Technology
Navigation Links
Activity in Biological Technology
... Cell of data demonstrating potent anti-cancer activity in colon and breast cancer models for the ... the risk for recurrence or more aggressive tumor activity by increasing the ratio of cancer stem cells ... Moreover, OMP-21M18 displayed additive activity in reducing tumor volume when combined with ...
... "ANA598 has demonstrated potent antiviral activity and good tolerability as a single agent in Phase ... of ANA598 that have demonstrated potent antiviral activity and good tolerability. In a monotherapy study in ... inhibitors. Furthermore, ANA598 retains full activity in vitro against mutations conferring resistance ...
... has demonstrated promising anti-angiogenic activity in preclinical studies. We are pleased to be ... MORPHODOMA((R)) technology, to improve the activity of the antibodies or develop new antibodies for ... small molecule compound(s) with significant activity minimizing solid tumors for cancer and ...
... a statistically significant decrease of epileptic activity in mice pre-treated with Kainic acid. "We ... to abnormal, excessive or synchronous neuronal activity in the brain. Epilepsy is one of the world's ... in the number of animals showing epileptic activity and delayed the onset of epileptic seizures. ...
... demonstrated sustained improvement in disease activity and patient response rate through four years of ... associated with sustained improvement in disease activity across multiple clinical measures, decreased ... improvement or stabilization of SLE disease activity and with decreased frequency of SLE disease ...
... cells and tumor markers both suggest single-agent activity warranting further clinical investigation. The ... mg). - No evidence of altered cardiac activity was observed. - Majority of adverse events ... that strongly suggest single agent anti-cancer activity for OGX-427," said Dr. Sebastien Hotte, Principal ...
... has demonstrated inhibition of PI-3 kinase activity at doses as low as 1 mg per patient. "We are ... to assess the tolerability and pharmacodynamic activity of both 24-hour and 72-hour infusions of PX-12. ... The compound has been shown to have anti-tumor activity both as a single agent and in combination with ...
... and Refractory CLL -- Early Promising Clinical activity As of the abstract submission, 10 patients ... patients demonstrated evidence of biological activity including high-risk patients. Two patients had ... the CD37 antigen and has shown potent anti-tumor activity in pre-clinical studies. Trubion initiated a ...
... on delafloxacin, one of which discusses the activity and efficacy of delafloxacin in a Phase 2 ... The second poster session details the in vitro activity of delafloxacin against a large, worldwide panel ... May 17, 1:30pm - Poster In vitro activity of Topic 31: New 2009 2:30pm ...
... has demonstrated increased antiviral activity when tested in combination with HCV protease ... Protease Inhibitor IDX316 exhibited potent activity against HCV NS3/4A proteases from multiple ... with tight binding to the HCV protease and no activity observed against eight human cellular proteases. ...
... absence of interferon, result in robust antiviral activity in treatment-naive HCV patients. INFORM-1 has ... to evaluate the safety and combined antiviral activity of ITMN-191 and R7128 in 14 days of combination ... to evaluate the safety and combined antiviral activity of R7227 (ITMN-191), a protease inhibitor, and ...
... the safety data as well as the promising clinical activity observed in this trial, Poniard initiated a ... regimen; both regimens have similar anti-tumor activity in first-line metastatic CRC. We are continuing ... drugs. Picoplatin has demonstrated anti-tumor activity in a variety of solid tumors. It is being studied ...
... -- One study, to determine whether the superior activity of the modified anti-CD20 human-mouse chimeric antibody exposed unexpected adverse activity that may not have been seen with the less ... The study determined that the increased target activity and cytotoxicity of DXL-modified anti-CD20 does ...
... (1) demonstrating the potent anti-tumor activity of a BiTE antibody binding to carcinoembryonic ... shows that novel BiTE antibodies have strong activity against CEA-expressing cancer cells in vitro and ... may not pose a limitation for the anti-tumor activity of BiTE antibodies." Reference ...
... Technology enhances biological activity (regenerative potential) of stem cells and ... technology for customizing the biological activity of cells for therapeutic use. This system, which ... ability to customize and enhance biological activity of cells and ensure robust product ...
... that optimize or augment the therapeutic activity of antibodies, and one important technology ... in development demonstrating enhanced anti-tumor activity in xenograft models, even with single doses as ... studies have also demonstrated that anti-tumor activity is maintained in drug-resistant cancer cells. ...
... that both regimens have similar anti-tumor activity in first-line metastatic CRC. Net sales in 2007 ... FOLPI regimen, but manageable. Anti-tumor activity also was similar in the FOLPI and FOLFOX groups. ... than 750 patients and has demonstrated anti-tumor activity in multiple indications with less severe kidney ...
... R7128's higher barrier to resistance and activity across multiple viral genotypes, as well as the ... of that molecule. R7128 has shown in vitro activity against all of the most common HCV genotypes (1, ... demonstrated significant short-term antiviral activity with safety and tolerability comparable to ...
... and R-Amphinase (R-Amph) show anti-tumor activity in chronic lymphocytic leukemia (CLL) and acute ... cell line. These reports now broaden ONCONASE's activity into CLL and AML, and include a related ... 72 hours of treatment, respectively. Synergistic activity was seen in the combination of the endonuclease ...
... lead product, carfilzomib, has single-agent activity and promotes durable responses in patients with ... Myeloma Research Consortium (MMRC). activity in Relapsed and Refractory Multiple Myeloma ... Myeloma (MM) (Abstract #864). Carfilzomib activity in Relapsed Patients by Prior Exposure to ...
... Demonstrates Proteasome Inhibition and Anti-Tumor activity SOUTH SAN FRANCISCO, Calif., Dec. 8 ... evaluated PR-047's mechanism, bioavailability and activity in a series of preclinical studies. Like ... PR-047 was shown to target the chymotrypsin-like activity of the proteasome and induce tumor cell death ...
... body-monitoring products can measure physical activity and calories burned with BodyMedia's level of ... upper left arm; o An Online activity Manager - which allows users to set and track ... for $199. Subscription rates for the Online activity Manager are between $6.95/month and $12.95/month, ...
... the Phase 2 Program Entitled, "The antitumoral activity and safety of AEZS-108 (AN-152), a LHRH agonist ... in a clinical study that targets the cytotoxic activity of doxorubicin specifically to LHRH-receptor expressing tumors. Finally, signs of anti-tumor activity were observed in 7 out of 13 patients treated ...
... Metabolic effects such as glucose lowering activity for the combination of insulin plus rHuPH20 were ... shifts insulin exposure and glucose lowering activity to earlier times and away from late postprandial times, insulin kinetics and activity for the combination of insulin plus rHuPH20 more ...
... from preclinical studies that demonstrate the activity of ceftaroline against methicillin-resistant ... was completed and ceftaroline demonstrated activity against a broad range of gram-positive pathogens ... / IDSA include the following: --Ceftaroline activity tested against organisms causing skin and ...
... following properties: - Stronger anti-HCV activity in fresh human hepatocytes infected with HCV ... than IFN alpha 2 drugs. - Stronger anti-HCV activity in vitro in the HCV genotype 1b subgenomic ... GEA007.1 exhibits a 7 fold superior inhibitory activity on HCV genotype 1b RNA synthesis compared to IFN ...
... and highlighted the significant anti-tumor activity and superior pharmacokinetic profile of NKTR-102. ... University of Arizona. "Additionally, the drug's activity in a number of tumor types, particularly in ... the safety, pharmacokinetics and anti-tumor activity of NKTR-102 monotherapy was evaluated in 57 ...
... that both regimens have similar anti-tumor activity in first-line metastatic CRC. "Picoplatin ... Society of Clinical Oncology in May. Anti-tumor activity also was found to be similar in the FOLPI ... than 750 patients and has demonstrated anti-tumor activity in multiple indications with less severe kidney ...
... "ANA598 has demonstrated potent antiviral activity and good tolerability as a single agent in Phase ... of ANA598 that have demonstrated potent antiviral activity and good tolerability. In a monotherapy study in ... inhibitors. Furthermore, ANA598 retains full activity in vitro against mutations conferring resistance ...
... has demonstrated promising anti-angiogenic activity in preclinical studies. We are pleased to be ... MORPHODOMA((R)) technology, to improve the activity of the antibodies or develop new antibodies for ... small molecule compound(s) with significant activity minimizing solid tumors for cancer and ...
... a statistically significant decrease of epileptic activity in mice pre-treated with Kainic acid. "We ... to abnormal, excessive or synchronous neuronal activity in the brain. Epilepsy is one of the world's ... in the number of animals showing epileptic activity and delayed the onset of epileptic seizures. ...
... demonstrated sustained improvement in disease activity and patient response rate through four years of ... associated with sustained improvement in disease activity across multiple clinical measures, decreased ... improvement or stabilization of SLE disease activity and with decreased frequency of SLE disease ...
Micromet Presents Update at ASCO 2009 on a Phase 1b Combination Study of Adecatumumab and Docetaxel
... Data indicate target-dependent activity in breast cancer patients with high expression of ... M. et al. (2009). Safety and anti-tumor activity of 3-weekly anti-EpCAM antibody adecatumumab ... of MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating ...... cells and tumor markers both suggest single-agent activity warranting further clinical investigation. The ... mg). - No evidence of altered cardiac activity was observed. - Majority of adverse events ... that strongly suggest single agent anti-cancer activity for OGX-427," said Dr. Sebastien Hotte, Principal ...
... has demonstrated inhibition of PI-3 kinase activity at doses as low as 1 mg per patient. "We are ... to assess the tolerability and pharmacodynamic activity of both 24-hour and 72-hour infusions of PX-12. ... The compound has been shown to have anti-tumor activity both as a single agent and in combination with ...
Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO
... activity of Blinatumomab in NHL and ALL Highlighted at the ... (3) Sebastian et al. (2009). Safety and antitumor activity of 3-weekly anti-EpCAM antibody adecatumumab ... is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating ...... and Refractory CLL -- Early Promising Clinical activity As of the abstract submission, 10 patients ... patients demonstrated evidence of biological activity including high-risk patients. Two patients had ... the CD37 antigen and has shown potent anti-tumor activity in pre-clinical studies. Trubion initiated a ...
... on delafloxacin, one of which discusses the activity and efficacy of delafloxacin in a Phase 2 ... The second poster session details the in vitro activity of delafloxacin against a large, worldwide panel ... May 17, 1:30pm - Poster In vitro activity of Topic 31: New 2009 2:30pm ...
UMass Boston Opens Venture Development Center to Expand R&D Activity
... expand the university's research and development activity and provide entrepreneurial opportunities for ... to the Dorchester waterfront." Research activity at UMass Boston has increased at a rate nearly ... the past five years. This expansion in research activity is helping to grow UMass Boston's role as an ...Telik Reports Preclinical Results at AACR Annual Meeting
... and carcinogenesis. Inhibition of Aurora kinase activity induces growth arrest and apoptosis in cells and ... Drug inhibition of aurora kinase and VEGFR activity in tumor samples of treated animals was ... vivo, TLK58747 demonstrated significant antitumor activity both orally and parenterally against a wide ...Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
... HCV patients that demonstrated potent antiviral activity over three days," said Steve Worland, Ph.D., ... sites. Potent Antiviral activity in HCV. Earlier today, Anadys presented ... in a late-breaker poster entitled, "Antiviral activity of ANA598, a Potent Non-Nucleoside Polymerase ...... has demonstrated increased antiviral activity when tested in combination with HCV protease ... Protease Inhibitor IDX316 exhibited potent activity against HCV NS3/4A proteases from multiple ... with tight binding to the HCV protease and no activity observed against eight human cellular proteases. ...
... absence of interferon, result in robust antiviral activity in treatment-naive HCV patients. INFORM-1 has ... to evaluate the safety and combined antiviral activity of ITMN-191 and R7128 in 14 days of combination ... to evaluate the safety and combined antiviral activity of R7227 (ITMN-191), a protease inhibitor, and ...
... the safety data as well as the promising clinical activity observed in this trial, Poniard initiated a ... regimen; both regimens have similar anti-tumor activity in first-line metastatic CRC. We are continuing ... drugs. Picoplatin has demonstrated anti-tumor activity in a variety of solid tumors. It is being studied ...
Ascenta Therapeutics Announces Results of Preclinical Evaluation of AT-406 in Multiple Cancer Models
... pipeline to demonstrate broad anti-cancer activity in pre-clinical models, including synergy with ... death (apoptosis) in tumor cells by blocking the activity of at least three "inhibitors of apoptosis ... the cancer cell. AT-406 is thought to mimic the activity of Smac (second mitochondria-derived activator of ...... -- One study, to determine whether the superior activity of the modified anti-CD20 human-mouse chimeric antibody exposed unexpected adverse activity that may not have been seen with the less ... The study determined that the increased target activity and cytotoxicity of DXL-modified anti-CD20 does ...
... (1) demonstrating the potent anti-tumor activity of a BiTE antibody binding to carcinoembryonic ... shows that novel BiTE antibodies have strong activity against CEA-expressing cancer cells in vitro and ... may not pose a limitation for the anti-tumor activity of BiTE antibodies." Reference ...
... Technology enhances biological activity (regenerative potential) of stem cells and ... technology for customizing the biological activity of cells for therapeutic use. This system, which ... ability to customize and enhance biological activity of cells and ensure robust product ...
Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609
... of over 250,000 new molecular entities with activity for a broad spectrum of infectious diseases. Orally bioavailable with excellent single-drug activity against Mycobacterium tuberculosis in vitro and in vivo , SQ609 has demonstrated synergistic activity with several front-line antitubercular drugs and ...... that optimize or augment the therapeutic activity of antibodies, and one important technology ... in development demonstrating enhanced anti-tumor activity in xenograft models, even with single doses as ... studies have also demonstrated that anti-tumor activity is maintained in drug-resistant cancer cells. ...
Seasonal Influenza Activity Increasing Across Europe - H3N2 Dominant Strain
... reports that in the 2008-2009 season, influenza activity is increasing rapidly across Europe. The first countries to report high intensity of influenza activity were Portugal and Ireland. To date, medium or high intensity activity has been reported in nineteen countries.(1) Of ...... that both regimens have similar anti-tumor activity in first-line metastatic CRC. Net sales in 2007 ... FOLPI regimen, but manageable. Anti-tumor activity also was similar in the FOLPI and FOLFOX groups. ... than 750 patients and has demonstrated anti-tumor activity in multiple indications with less severe kidney ...
First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer
... drug conjugate that has demonstrated therapeutic activity in patients. In addition to the Phase 2 clinical ... profile that has demonstrated therapeutic activity in patients. Positive Phase 1 data for ... highlighted the compound's significant anti-tumor activity and superior pharmacokinetic profile. Patients ...... R7128's higher barrier to resistance and activity across multiple viral genotypes, as well as the ... of that molecule. R7128 has shown in vitro activity against all of the most common HCV genotypes (1, ... demonstrated significant short-term antiviral activity with safety and tolerability comparable to ...
... and R-Amphinase (R-Amph) show anti-tumor activity in chronic lymphocytic leukemia (CLL) and acute ... cell line. These reports now broaden ONCONASE's activity into CLL and AML, and include a related ... 72 hours of treatment, respectively. Synergistic activity was seen in the combination of the endonuclease ...
... lead product, carfilzomib, has single-agent activity and promotes durable responses in patients with ... Myeloma Research Consortium (MMRC). activity in Relapsed and Refractory Multiple Myeloma ... Myeloma (MM) (Abstract #864). Carfilzomib activity in Relapsed Patients by Prior Exposure to ...
EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma
... safety, tolerability, pharmacodynamic effects and activity of ENMD-2076 in this patient population. ... in vitro indicated synergistic cytotoxic activity towards several human multiple myeloma cell ... B. ENMD-2076 has shown significant cytotoxic activity preclinically towards a variety of human leukemia ...... Demonstrates Proteasome Inhibition and Anti-Tumor activity SOUTH SAN FRANCISCO, Calif., Dec. 8 ... evaluated PR-047's mechanism, bioavailability and activity in a series of preclinical studies. Like ... PR-047 was shown to target the chymotrypsin-like activity of the proteasome and induce tumor cell death ...
... body-monitoring products can measure physical activity and calories burned with BodyMedia's level of ... upper left arm; o An Online activity Manager - which allows users to set and track ... for $199. Subscription rates for the Online activity Manager are between $6.95/month and $12.95/month, ...
/C O R R E C T I O N -- Rosetta Genomics Ltd/
... Since many diseases are caused by the abnormal activity of proteins, the ability to selectively regulate protein activity through microRNAs could provide the means ... Since many diseases are caused by the abnormal activity of proteins, the ability to selectively regulate ...... the Phase 2 Program Entitled, "The antitumoral activity and safety of AEZS-108 (AN-152), a LHRH agonist ... in a clinical study that targets the cytotoxic activity of doxorubicin specifically to LHRH-receptor expressing tumors. Finally, signs of anti-tumor activity were observed in 7 out of 13 patients treated ...
... Metabolic effects such as glucose lowering activity for the combination of insulin plus rHuPH20 were ... shifts insulin exposure and glucose lowering activity to earlier times and away from late postprandial times, insulin kinetics and activity for the combination of insulin plus rHuPH20 more ...
... from preclinical studies that demonstrate the activity of ceftaroline against methicillin-resistant ... was completed and ceftaroline demonstrated activity against a broad range of gram-positive pathogens ... / IDSA include the following: --Ceftaroline activity tested against organisms causing skin and ...
... following properties: - Stronger anti-HCV activity in fresh human hepatocytes infected with HCV ... than IFN alpha 2 drugs. - Stronger anti-HCV activity in vitro in the HCV genotype 1b subgenomic ... GEA007.1 exhibits a 7 fold superior inhibitory activity on HCV genotype 1b RNA synthesis compared to IFN ...
... and highlighted the significant anti-tumor activity and superior pharmacokinetic profile of NKTR-102. ... University of Arizona. "Additionally, the drug's activity in a number of tumor types, particularly in ... the safety, pharmacokinetics and anti-tumor activity of NKTR-102 monotherapy was evaluated in 57 ...
EntreMed's ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
... ENMD-2076 is a novel kinase inhibitor with potent activity against Aurora A and a number of tyrosine kinases ... a substantial decrease in tumor metabolic activity in animals treated with ENMD-2076. ENMD-2076 ... mechanisms of action, including antiproliferative activity and the inhibition of angiogenesis. ENMD-2076 has ...... that both regimens have similar anti-tumor activity in first-line metastatic CRC. "Picoplatin ... Society of Clinical Oncology in May. Anti-tumor activity also was found to be similar in the FOLPI ... than 750 patients and has demonstrated anti-tumor activity in multiple indications with less severe kidney ...
Other ContentsterminalterminalterminalterminalterminalterminalterminalterminalterminallaminalaminalaminanuclearnuclearnuclearnuclearnuclearnuclearnuclearnuclearnuclearnucleolusnucleosidenucleosidenucleosidenucleosidenucleosidenucleosidenucleotidenucleotidenucleotidenucleotidenucleotidenucleotidenucleotidenucleosomenucleosomeOther TagsIntermittentMentallyRiskyHypnosisFoodsFoodsEasingEasingEasingAbstinenceSymptomsSymptomsSymptomsEfficacyEfficacy
(Date:11/26/2009)...9 What are the bare essentials of life, the indis...at can survive on its own? Can we describe the mol...tire organism functions as a system? These are jus...ership between the European Molecular Biology Labo...re de Regulacio Genmica (CRG) in Barcelona, Spain,...
(Date:11/25/2009)...police officers and ambulance workers faced a terr...plex. They battled to save people from the collaps...ires and evacuated as many people as they could in...e. And making their jobs even harder was the probl...their relatives jammed mobile networks with calls ...
(Date:11/25/2009)...be just as vital to your health as what you eat, f...cal Studies. Their experiments in mice revealed th...es in the liverthe body,s metabolic clearinghousei...body,s circadian clock as conventional wisdom had ...of a large number of genes completely independent ...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 14743 1DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 14743 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 14743 3Transgenomic Inc Reports Third Quarter 2009 Results 14739 1Transgenomic Inc Reports Third Quarter 2009 Results 14739 2Transgenomic Inc Reports Third Quarter 2009 Results 14739 3Transgenomic Inc Reports Third Quarter 2009 Results 14739 4Transgenomic Inc Reports Third Quarter 2009 Results 14739 5Transgenomic Inc Reports Third Quarter 2009 Results 14739 6Transgenomic Inc Reports Third Quarter 2009 Results 14739 7Orange County Dermatologist Garners Outstanding Results With New Thermage CPT 28R 29 6034 1Orange County Dermatologist Garners Outstanding Results With New Thermage CPT 28R 29 6034 2(Date:11/27/2009)... XenaCare Holdings has announced that it has ...ion, one of the largest nonprofit organizations de...ucation. , Delray Beach, ... Inc. (OTCBB: XCHO), a company specializing in the...lthcare products, has announced today that is has ...
(Date:11/27/2009)... Voyant Health™ announced today that Sp...d its TraumaCad Enterprise orthopedic templating s.... , (PRWEB) November 27, ...Spectrum Health (Grand Rapids, Michigan) has licen... solution and its TraumaCad Extend workflow soluti...
(Date:11/26/2009)...27/PRNewswire/--Withcoldandfluseasonuponus,it,smor...espreadofinfectionsandavoidillness. ,, "Weneedt...idtransmittingillnessifwe,resick,"saidEileenFinert...irectorforinfectioncontrolandoccupationalhealthatH...spitalforSpecialSurgeryhasoneofthelowestinfectionr...
(Date:11/26/2009)...ig or too heavy can lead to strains or worse , ...re may be nothing wrong with stuffing your turkey ... same thing with your suitcase as you pack for hol...ted in 2008 in U.S. hospital emergency rooms, doct... for luggage-related injuries, such as muscle stra...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a leadi..., today announced the expansion of its services to..., Dr. Doug Macmillan. , ...s pleased to announce that Dr. Doug Macmillan, an ...d an additional advanced training seminar. RTDent...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2[0] XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation [0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend[1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use[2] Pack Right for the Holidays to Avoid the ER[0] Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental
IntermittentStockingsBiofeedbackMentallyRiskyAdoptingHypnosisFoodsEasingAbstinenceSymptomsEfficacyLycopeneMixing
Other Tagsnutrients 2nutrients 3nutrients 4nutrients 5nutrients 6nutrients 7nutrients 8bridge 2identifying 2identifying 3identifying 4identifying 5identifying 6identifying 7identifying 8identifying 9identifying 10
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |